参考文献/References:
[1] Zhu Q,Pan P,Chen X,et al.Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1:Identity,regulation and environmental inhibitors[J].Toxicology,2019,425:152253.DOI:10.1016/j.tox.2019.152253.
[2] Simard J,Ricketts ML,Gingras S,et al.Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family[J].Endocr Rev,2005,26(4):525-582.DOI:10.1210/er.2002-0050.
[3] 黄海花,朱岷.3β羟基类固醇脱氢酶缺乏症的研究进展[J].儿科药学杂志,2020,26(8):58-62.DOI:10.13407/j.cnki.jpp.1672-108X.2020.08.019.
[4] Michael P,Roversi G,Brown K,et al.Adrenal steroids and resistance to hormonal blockade of prostate and breast cancer[J].Endocrinology,2023,164(3):bqac218.DOI:10.1210/endocr/bqac218.
[5] Li D,Liu R,Wang M,et al.3β-Hydroxysteroid dehydrogenase expressed by gut microbes degrades testosterone and is linked to depression in males[J].Cell Host Microbe,2022,30(3):329-339.e5.DOI:10.1016/j.chom.2022.01.001.
[6] Thomas JL,Bucholtz KM,Kacsoh B.Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer[J].J Steroid Biochem Mol Biol,2011,125(1-2):57-65.DOI:10.1016/j.jsbmb.2010.08.003.
[7] Lee SH,Park SY,Choi CS.Insulin resistance:from mechanisms to therapeutic strategies[J].Diabetes Metab J,2022,46(1):15-37.DOI:10.4093/dmj.2021.0280.
[8] Oh JY,Barrett-Connor E,Wedick NM,et al.Endogenous sex hormones and the development of type 2 diabetes in older men and women:the Rancho Bernardo study[J].Diabetes Care,2002,25(1):55-60.DOI:10.2337/diacare.25.1.55.
[9] Nna VU,Bakar ABA,Ahmad A,et al.Down-regulation of steroidogenesis-related genes and its accompanying fertility decline in streptozotocin-induced diabetic male rats:ameliorative effect of metformin[J].Andrology,2019,7(1):110-123.DOI:10.1111/andr.12567.
[10] Wagner IV,Klöting N,Savchuk I,et al.Diabetes type 1 negatively influences leydig cell function in rats,Which is partially reversible by insulin treatment[J].Endocrinology,2021,162(4):bqab017.DOI:10.1210/endocr/bqab017.
[11] Hu Y,Wang Y,Cai T,et al.Short-time intensive insulin therapy upregulates 3 beta-and 17 beta-hydroxysteroid dehydrogenase levels in men with newly diagnosed T2DM[J].Front Endocrinol(Lausanne),2022,13:894743.DOI:10.3389/fendo.2022.894743.
[12] Kiani AK,Mor M,Bernini A,et al.Steroid-converting enzymes in human adipose tissues and fat deposition with a focus on AKR1C enzymes[J].Eur Rev Med Pharmacol Sci,2021,25(1 Suppl):23-32.DOI:10.26355/eurrev_202112_27330.
[13] Tchernof A,Mansour MF,Pelletier M,et al.Updated survey of the steroid-converting enzymes in human adipose tissues[J].J Steroid Biochem Mol Biol,2015,147:56-69.DOI:10.1016/j.jsbmb.2014.11.011.
[14] Blouin K,Nadeau M,Mailloux J,et al.Pathways of adipose tissue androgen metabolism in women:depot differences and modulation by adipogenesis[J].Am J Physiol Endocrinol Metab,2009,296(2):E244-E255.DOI:10.1152/ajpendo.00039.2008.
[15] Ta N,A L,E E,et al.Metabolomics analysis reveals amelioration effects of yellowhorn tea extract on hyperlipidemia,inflammation,and oxidative stress in high-fat diet-fed mice[J].Front Nutr,2023,10:1087256.DOI:10.3389/fnut.2023.1087256.
[16] Kannan S,Srinivasan D,Raghupathy PB,et al.Association between duration of obesity and severity of ovarian dysfunction in rat-cafeteria diet approach[J].J Nutr Biochem,2019,71:132-143.DOI:10.1016/j.jnutbio.2019.05.012.
[17] Suleiman JB,Nna VU,Othman ZA,et al.Orlistat attenuates obesity-induced decline in steroidogenesis and spermatogenesis by up-regulating steroidogenic genes[J].Andrology,2020,8(5):1471-1485.DOI:10.1111/andr.12824.
[18] Kupczyk D,Bilski R,Kozakiewicz M,et al.11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases[J].Int J Mol Sci,2022,23(16):8984.DOI:10.3390/ijms23168984.
[19] 钟宝,彭诚,Cha Y.高脂高盐饮食对大鼠醛固酮分泌和高血压的影响[J].营养学报,2021,43(4):384-388.DOI:10.3969/j.issn.0512-7955.2021.04.013.
[20] Tsilosani A,Gao C,Zhang W.Aldosterone-Regulated sodium transport and blood pressure[J].Front Physiol,2022,13:770375.DOI:10.3389/fphys.2022.770375.
[21] Murrell JR,Randall JD,Rosoff J,et al.Endogenous ouabain:upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal[J].Circulation,2005,112(9):1301-1308.DOI:10.1161/CIRCULATIONAHA.105.554071.
[22] Simonini M,Casanova P,Citterio L,et al.Endogenous ouabain and related genes in the translation from hypertension to renal diseases[J].Int J Mol Sci,2018,19(7):1948.DOI:10.3390/ijms19071948.
[23] Salvi E,Wang Z,Rizzi F,et al.Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide[J].Hypertension,2017,69(1):51-59.DOI:10.1161/HYPERTENSIONAHA.116.08267.
[24] Froment P,Plotton I,Giulivi C,et al.At the crossroads of fertility and metabolism:the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism[J].Hum Reprod,2022,37(6):1207-1228.DOI:10.1093/humrep/deac067.
[25] Piotrowska A,Pilch W,Czerwińska-Ledwig O,et al.The possibilities of using chromium salts as an agent supporting treatment of polycystic ovary syndrome[J].Biol Trace Elem Res,2019,192(2):91-97.DOI:10.1007/s12011-019-1654-5.
[26] Yu J,Liu Y,Zhang D,et al.Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS[J].J Endocrinol,2019,JOE-18-0678.R2.DOI:10.1530/JOE-18-0678.
[27] Friedman SL,Neuschwander-Tetri BA,Rinella M,et al.Mechanisms of NAFLD development and therapeutic strategies[J].Nat Med,2018,24(7):908-922.DOI:10.1038/s41591-018-0104-9.
[28] Ge MX,Niu WX,Ren JF,et al.A novel ASBT inhibitor,IMB17-15,repressed nonalcoholic fatty liver disease development in high-fat diet-fed syrian golden hamsters[J].Acta Pharmacol Sin,2019,40(7):895-907.DOI:10.1038/s41401-018-0195-3.
[29] Zhao J,Setchell KDR,Gong Y,et al.Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase(HSD3B7)deficiency in China[J].Orphanet J Rare Dis,2021,16(1):417.DOI:10.1186/s13023-021-02041-7.
相似文献/References:
[1]艾华,谢岚.Irisin与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(05):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
Ai Hua,Xie Lan.Relationship between irisin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
[2]陈恺情,卜瑞芳.Irisin——可否让代谢性疾病治疗进入新时代[J].国际内分泌代谢杂志,2016,36(01):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
Chen Kaiqing,Bu Ruifang..Could irisin lead the treatment of metabolic diseases into a new era?[J].International Journal of Endocrinology and Metabolism,2016,36(01):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
[3]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行
特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(01):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[4]祝凌妃,杨震,秦利.肌肉因子与代谢性疾病[J].国际内分泌代谢杂志,2016,36(05):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
Zhu Lingfei,Yang Zhen,Qin li.Myokines and metabolic disease[J].International Journal of Endocrinology and Metabolism,2016,36(01):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
[5]项芬芬,张学梅,高英慧,等.p53与物质能量代谢的关系[J].国际内分泌代谢杂志,2017,37(04):262.
Xiang Fenfen*,Zhang Xuemei,Gao Yinghui,et al.Relationship between p53 and material, energy metabolism[J].International Journal of Endocrinology and Metabolism,2017,37(01):262.
[6]杨雪 相萍萍 陈国芳 刘超.IGF-1在代谢性疾病中的作用[J].国际内分泌代谢杂志,2018,38(01):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
Yang Xue,Xiang Pingping,Chen Guofang,et al.Effects of IGF-1 in metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(01):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
[7]杨雪 韦晓 杨婉薇 陈国芳 刘超.代谢组学在糖尿病研究中的应用[J].国际内分泌代谢杂志,2018,38(05):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
Yang Xue,Wei Xiao,Yang Wanwei,et al.Application of metabonomics in diabetic research[J].International Journal of Endocrinology and Metabolism,2018,38(01):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
[8]王佳蓓 陈风 刘莹 王涤非.Nur77与物质能量代谢的关系[J].国际内分泌代谢杂志,2019,39(01):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
Wang Jiabei,Chen Feng,Liu Ying,et al.Relationship between Nur77 and meterial, energy metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
[9]王雪 朱惠娟 龚凤英.棕色脂肪因子与代谢性疾病[J].国际内分泌代谢杂志,2019,39(06):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
Wang Xue,Zhu Huijuan,Gong Fengying.Relationship between brown adipocytokine and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2019,39(01):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
[10]王鹏程,姜长涛.肠源神经酰胺与代谢性疾病[J].国际内分泌代谢杂志,2021,41(04):295.[doi:10.3760/cma.j.cn121383-20200610-06029]
Wang Pengcheng,Jiang Changtao..Relationship between intestinal ceramide and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2021,41(01):295.[doi:10.3760/cma.j.cn121383-20200610-06029]